|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01143311 |
|
Date of registration:
|
19/04/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Role of microRNA in the Development of Cutaneous Squamous Cell Carcinoma
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
June 2010 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Terminated |
|
URL:
|
http://clinicaltrials.gov/show/NCT01143311 |
|
Study type:
|
Interventional |
|
Study design:
|
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Thierry Passeron, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
CHU de Nice - Service de Dermatologie - Hôpital de l'Archet - 151 Route de saint-antoine de ginestière 06200 Nice |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patient older than 40th, suffering of a C-SCC
- letter of consent signed by the patient
- to be registered to social security
Exclusion Criteria:
- Pregnant women or breastfeeding.
- Small C-SCC (size < 6mm)
- Allergy to Xylocaine
- All vulnerable (minor, adult guardianship…)
Age minimum:
40 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Cancer of the Skin
|
|
Intervention(s)
|
|
Genetic: Arm A
|
|
Primary Outcome(s)
|
|
miRNAs
[Time Frame: 1 year]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|